We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit
MTACU

Delisted

MTACU was delisted on the 10th of August, 2023.

Back to rankings

4 hedge funds and large institutions have $424K invested in MedTech Acquisition Corporation Unit in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less capital invested

Capital invested by funds: $474K → $424K (-$50K)

20% less funds holding

Funds holding: 5 → 4 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$3.01K

Top Sellers

Rank Fund Capital Flow
1
ICMH
Integrity Capital Management (HK)
Hong Kong
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
1
HRT Financial
New York
$418K – – –
UBS Group
2
UBS Group
Switzerland
$4K +$3.01K +306 +306%
TRCT
3
Tower Research Capital (TRC)
New York
$2K – – –
ICMH
4
Integrity Capital Management (HK)
Hong Kong
– -$46K -4,700 Closed

MTACU Hedge Fund Activity: Q2 2022 in Review

4 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q2 2022, worth a combined $424K — down 11% from $474K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MTACU and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $3.01K. The largest seller was Integrity Capital Management (HK), exiting entirely with an estimated $46K sold.

  • 4 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q2 2022, down from 5 in Q1 2022.
  • Funds reported $424K of MedTech Acquisition Corporation Unit stock for Q2 2022, down 11% quarter-over-quarter.
  • 0 funds opened new MedTech Acquisition Corporation Unit positions in Q2 2022 and 1 closed out, a net change of -1 holder.
  • The largest MedTech Acquisition Corporation Unit buyer in Q2 2022 was UBS Group, an estimated $3.01K added.
  • The largest MedTech Acquisition Corporation Unit seller in Q2 2022 was Integrity Capital Management (HK), an estimated $46K sold.

Based on aggregated 13F filings for Q2 2022.